2024-10-18 - Analysis Report
## Thermo Fisher Scientific Inc (TMO) Stock Analysis Report

**Company Overview:** Thermo Fisher Scientific Inc is a leading provider of scientific instruments, reagents, consumables, and software services for research, analysis, discovery, and diagnostics.

**Performance Analysis:**

**1.  Return Performance:**

*   **Cumulative Return:** 238.0%
*   **S&P 500 (VOO) Cumulative Return:** 136.93%
*   **Return Difference:** 101.07% (The stock has outperformed the S&P 500 by 101.07%)
*   **Relative Strength:** 46.86% (This indicates that the stock's performance is in the 46.86th percentile compared to its historical range.) 

**2.  Recent Price Movement:**

*   **Closing Price:** 591.55
*   **5-day Moving Average:** 596.96
*   **20-day Moving Average:** 605.68
*   **60-day Moving Average:** 606.91
*   **Interpretation:** The stock is currently trading below its 5-, 20-, and 60-day moving averages, suggesting a short-term downtrend.

**3.  Technical Indicators:**

*   **RSI:** 26.87 (This suggests that the stock is currently in oversold territory.)
*   **PPO:** -0.24 (A negative PPO indicates a potential bearish trend.)
*   **Delta_Previous_Relative_Divergence:** -8.79 (Negative value indicates a recent short-term downtrend.)
*   **Expected Return:** 13.979739075% (This is the expected 5-year return based on historical data and compared to the S&P 500)

**4.  Recent Earnings and Forecasts:**

| Date       | EPS   | Revenue  |
| :--------- | :---- | :------- |
| 2024-08-02 | 4.05  | 10.54 B$ |
| 2024-05-03 | 3.47  | 10.35 B$ |
| 2023-11-03 | 4.44  | 10.57 B$ |
| 2023-08-04 | 3.53  | 10.69 B$ |
| 2024-08-02 | 3.53  | 10.69 B$ |

**Analysis:** 
The company has consistently exceeded revenue estimates, but EPS performance has been more volatile. The most recent earnings report for Q2 2024 showed a slight miss on EPS, but beat revenue expectations. This suggests that the company may face short-term challenges in profitability, but remains strong in revenue generation.

**5.  News and Recent Issues:**

**Recent Market Outlook for given stock:** According to FINBOLD, Thermo Fisher Scientific Inc (TMO) is considered a strong stock, with strong revenue growth potential. 

**Analyst Opinions and Performance Highlights:**

*  Analysts are generally bullish on the company's future prospects, citing its strong market position and growth potential in areas like diagnostics and life sciences.
*  However, some concerns remain about potential macroeconomic headwinds and the company's ability to maintain its high margins.
*  Overall, the stock is seen as a solid long-term investment, but investors may want to consider its current valuation and potential short-term risks.

**6.  Overall Analysis:**

Thermo Fisher Scientific Inc has consistently outperformed the market in terms of total return. While its recent price action suggests a short-term downtrend, the company remains fundamentally strong with robust revenue growth and a solid market position. The stock is currently trading in oversold territory, which could present a buying opportunity for long-term investors. However, investors should be aware of potential short-term risks associated with macroeconomic uncertainty and margin compression.

**7.  Recommendations:**

*   Long-term investors with a high-risk tolerance may consider adding Thermo Fisher Scientific Inc to their portfolio.
*   Short-term investors may want to wait for the stock to show signs of a rebound before entering a position.
*   It is essential to monitor the company's future earnings reports and industry trends to make informed investment decisions. 
